Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @US_FDA: @SGottliebFDA FDA Commissioner @SGottliebFDA spoke today @PressClubDC – full remarks here https://t.co/MDYTbN2s3o
SteveFDA (R-D.C.)
@SGottliebFDA
RT @charlesornstein: .@SGottliebFDA is on it. https://t.co/IKCBsgwasH
SteveFDA (R-D.C.)
@SGottliebFDA
Hey @ikeswetlitz that looks like a Pre-Mixed Amalgamate (PMA) https://t.co/oTeNblKs1j QT @ikeswetlitz: @US_FDA @SGottliebFDA Too bad this isn't a medical device -- otherwise it might be a 510ca(k)e! https://t.co/Gk8gAbbNwu)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: FDA is widening the scope of a new tool to facilitate pre-approval access to drugs https://t.co/uTfwL8EVXx
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: New #FDA educational program for tobacco retailers aims to prevent underage sales of tobacco products to minors https://t.co/Hd2w3L9KJJ
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA taking fresh look at regulation of novel medical advances like digital health, regenerative med, genetic tests https://t.co/UP2wUyNwx0
SteveFDA (R-D.C.)
@SGottliebFDA
RT @NatureBiotech: Speed and oversight: @US_FDA Commissioner Gottlieb acts on pledges - @CT_Morrison https://t.co/MLmfWtDijT #FDARA https://t.co/baipncqagA
SteveFDA (R-D.C.)
@SGottliebFDA
Today, #FDA finalized guidance to help bring more Hepatitis C treatments to the market https://t.co/LRU9JSdibH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @lauriemcginley2: Statement from @SGottliebFDA on "streamlined review pathway" for consumer tests that evaluate genetic health risks https://t.co/7EayckdWOJ
SteveFDA (R-D.C.)
@SGottliebFDA
The finalized #FDA guidance will help provide more Hepatitis C treatment options https://t.co/LRU9JSdibH
SteveFDA (R-D.C.)
@SGottliebFDA
We need continued innovation in Hep C treatment R&D; we’re giving industry new guidance on direct-acting antivirals https://t.co/LRU9JSdibH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @DonnaYoungDC: Here's #FDA's guidance: Chronic #HepatitisC Virus Infection: Developing Direct-Acting Antiviral Drugs… QT @SGottliebFDA: The finalized #FDA guidance will help provide more Hepatitis C treatment options https://t.co/LRU9JSdibH)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @CliftonLeaf: New statement from #FDA on encouraging advances in #digitalhealth: https://t.co/o14oVJNJGT @SGottliebFDA https://t.co/KXAO… QT @SGottliebFDA: #FDA taking fresh look at regulation of novel medical advances like digital health, regenerative med, genetic tests https://t.co/UP2wUyNwx0)
SteveFDA (R-D.C.)
@SGottliebFDA
RT @StephanieSimon_: FDA clears the way for more consumer genetic health tests to hit the market https://t.co/3k8wvDqkWR via @statnews
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA sets forth new, more efficient pathway for clearance of genetic risk tests, other innovative medical advances https://t.co/UP2wUyNwx0
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SeemaCMS: Excited to speak today at the #NAMD2017 @statemedicaid conference about @CMSGov's vision for #Medicaid in 2017 & beyond.
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA taking fresh look at regulation of novel medical advances like digital health, regenerative med, genetic tests https://t.co/UP2wUyNwx0
SteveFDA (R-D.C.)
@SGottliebFDA
RT @HHSMedia: Healthcare Providers: Strong Vaccination Recommendation Can Be Game-Changer this #FluSeason says @Surgeon_General… https://t.co/hZKuXQBuaO
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: We need continued innovation in Hep C treatment R&D; we’re giving industry new guidance on direct-acting antivirals https://t.co/LRU9JSdibH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @hbottemiller: Super interesting line in this FDA statement: A hint that agency has broader policy effort coming on nutrition � https://t.co/DwMpCxZGfO